Retour sur lavenir.net
   ENERGYVISION 14.500 € (+1,26 %)     IBA 16.900 € (-2,87 %)     TITAN S.A. 52.100 € (+3,17 %)     QRF 10.800 € (+0,47 %)     WERELDHAVE BELGIUM 52.600 € (+0,77 %)     VASTNED 30.150 € (+0,84 %)     WDP 22.160 € (+1,93 %)     PROXIMUS 6.530 € (-0,08 %)     UMICORE 22.640 € (+3,66 %)     KBC ANCORA 79.100 € (+3,53 %)     SOFINA 216.800 € (+2,26 %)     ARGENX SE 783.600 € (+1,03 %)     CIE BOIS SAUVAGE 310.000 € (+1,97 %)     ONWARD MEDICAL 2.625 € (-0,94 %)     FAGRON 24.750 € (+1,43 %)     GIMV 45.400 € (+2,37 %)     JENSEN-GROUP 84.400 € (+0,72 %)     MONTEA 67.000 € (+1,98 %)     HOME INVEST BE. 19.860 € (-0,30 %)     NYRSTAR 0.064 € (-8,31 %)     ONTEX GROUP 2.465 € (0,00 %)     AGFA-GEVAERT 0.423 € (+0,12 %)     RETAIL ESTATES 70.800 € (-0,14 %)     ASCENCIO 52.500 € (+2,74 %)     VIOHALCO 19.080 € (-1,75 %)     SOLVAC NOM(RETAIL) 76.000 € (+1,33 %)     TINC 11.860 € (+0,85 %)     MELEXIS 80.600 € (-0,68 %)     ACKERMANS V.HAAREN 280.000 € (+3,86 %)     LOTUS BAKERIES 11 700.000 € (-0,68 %)     CAMPINE 229.000 € (+0,44 %)     IMMOBEL 20.800 € (-0,95 %)     AB INBEV 71.280 € (+0,28 %)     D'IETEREN GROUP 169.500 € (+2,54 %)     VGP 81.800 € (+3,28 %)     AZELIS GROUP 10.430 € (+1,46 %)     CMB.TECH 13.320 € (+0,60 %)     EKOPAK 4.050 € (-1,22 %)     TESSENDERLO 20.350 € (+2,36 %)     CENERGY 24.100 € (-0,66 %)     BANQUP GROUP 1.545 € (+1,98 %)     BPOST 1.700 € (+1,31 %)     TUBIZE-FIN 241.800 € (+2,37 %)     RECTICEL 10.700 € (+2,10 %)     AEDIFICA 70.800 € (+1,80 %)     GBL 80.400 € (+1,20 %)     NYXOAH 1.406 € (-2,36 %)     SOLVAY 26.800 € (+1,98 %)     HYBRID SOFTWARE GR 4.060 € (+1,00 %)     SHURGARD 24.050 € (+2,78 %)     EVS 30.000 € (-0,17 %)     CARE PROPERTY INV. 12.380 € (-0,32 %)     COFINIMMO 83.100 € (+1,65 %)     BARCO 8.565 € (+1,24 %)     ECONOCOM GROUP 1.540 € (-1,91 %)     WHAT'S COOKING GP 146.000 € (0,00 %)     KBC 114.600 € (+3,38 %)     AGEAS 66.600 € (+1,14 %)     BREDERODE 103.000 € (+1,78 %)     XIOR 26.650 € (+1,14 %)  
   STMICROELECTRONICS 67.750 € (+4,47 %)     CALIBRE 0.000 € (-25,00 %)     AKZO NOBEL 57.780 € (+2,05 %)     SAINT GOBAIN 75.760 € (+3,38 %)     FUGRO 11.930 € (+0,85 %)     VINCI 125.900 € (+2,07 %)     BNP PARIBAS ACT.A 96.690 € (+5,17 %)     TOTALENERGIES 76.380 € (-2,08 %)     EURAZEO 42.480 € (+1,34 %)     BILENDI 15.200 € (0,00 %)     PULLUP ENTERTAIN 9.690 € (+10,11 %)     AXA 40.860 € (+0,96 %)     KALRAY 11.120 € (+12,66 %)     SANOFI 76.590 € (+0,38 %)     WOLTERS KLUWER 61.100 € (+0,69 %)     SIRIUS MEDIA 1.150 € (-11,54 %)     SCOR SE 31.040 € (+0,32 %)     INPOST 15.320 € (+0,20 %)     SAFRAN 306.100 € (+3,66 %)     ARCELORMITTAL SA 60.600 € (+5,87 %)     CORBION 20.160 € (+1,66 %)     MEDINCELL 27.420 € (-1,01 %)     NEXITY 7.830 € (+1,82 %)     TONNER DRONES 0.031 € (-9,73 %)     SCHNEIDER ELECTRIC 265.300 € (+0,38 %)     V LANSCHOT KEMPEN 68.500 € (+3,24 %)     AEGON 7.294 € (+2,76 %)     EUTELSAT COMMUNIC. 2.937 € (+0,14 %)     ASML HOLDING 1 629.600 € (+3,40 %)     ASM INTERNATIONAL 1 015.000 € (+4,25 %)     LUMIBIRD 24.000 € (+2,13 %)     MAISONS DU MONDE 0.437 € (+4,05 %)     HAFFNER ENERGY 0.276 € (+11,76 %)     AVANTIUM 7.800 € (+5,69 %)     ENGIE 27.510 € (+0,36 %)     CATANA GROUP 2.245 € (0,00 %)     PLUXEE 11.150 € (+1,73 %)     EXAIL TECHNOLOGIES 100.600 € (-16,17 %)     KAUFMAN ET BROAD 24.250 € (+0,83 %)     GENFIT 9.260 € (+4,99 %)     BE SEMICONDUCTOR 317.000 € (+2,96 %)     FORVIA 9.846 € (+4,57 %)     S.E.B. 55.050 € (+3,48 %)     EIFFAGE 126.500 € (+1,98 %)     ADYEN 828.400 € (+5,50 %)     LVMH 510.600 € (+3,53 %)     REWORLD MEDIA 1.700 € (-0,23 %)     CAPGEMINI 96.720 € (+1,32 %)     ABN AMRO BANK N.V. 34.670 € (+3,18 %)     VALEO 14.530 € (+1,82 %)     ALFEN 14.610 € (+1,25 %)     CRCAM BRIE PIC2CCI 37.600 € (+1,38 %)     SOCIETE GENERALE 73.400 € (+6,15 %)     ING GROEP N.V. 25.960 € (+3,55 %)     AIR FRANCE -KLM 11.855 € (+8,36 %)     STELLANTIS NV 5.900 € (+1,88 %)     L'OREAL 390.250 € (+1,81 %)     SES 8.250 € (+1,85 %)     UMG 17.760 € (+0,14 %)     GENOWAY 2.400 € (0,00 %)  
News Réglementées
31/01/2023 15:00

Venom Ventures Fund Commits a $5 Million Strategic Investment in the Everscale Blockchain

Chainwire
Venom Ventures Fund Commits a $5 Million Strategic Investment in the Everscale Blockchain

31-Jan-2023 / 14:00 GMT/BST


 

As part of the strategic partnership, Venom and Everscale will be working together to bring the adoption of blockchain closer to real business use cases.

Abu Dhabi, 31 January 2023 Venom Ventures Fund, a Web3 and blockchain innovation fund managed by Abu Dhabi-based investment fund manager Iceberg Capital Limited, has announced a strategic partnership with Everscale, a premier blockchain that aims to solve the scalability issues bogging down the Web3 industry.

Venom Ventures Fund has committed a $5 million investment in Everscale to help it further expand its development teams and boost the number of projects. The investment will be in stages, based on the progress and cooperation indicators.

Everscale has been diligently working on expanding its reach and integrating its technology solutions in Asian countries over the past two years, while also building a strong community. Its dynamic sharding technology enables it to efficiently adapt to varying workloads, thus making it an easy and practical option for creating large-scale Web3 and other types of applications.

The Venom Ventures Fund was launched by Iceberg Capital Limited in partnership with Venom Foundation, the first officially licensed and regulated Layer-1 blockchain operating within the Abu Dhabi Global Market (ADGM).

Venom Ventures Fund Chairman Peter Knez, ex-CIO of BlackRock, said, “For us, this is a strategic investment aimed at the technological development of projects and teams around technologies that we focus on and actively develop. In particular, we are talking about the Venom blockchain project and its ecosystem, which is planned to be launched soon and for which Everscale is a potential Layer 2 solution.”

 

Venom and Everscale teams will be working together on the further development of the core and the ecosystem bringing the adoption of blockchain closer to real business use cases. Current initiatives such as digital asset tokenization platforms, a full framework for CBDCs and stablecoins and payment solutions with crypto to fiat gateways are already making good headway.

 

Commenting on the investment, Everscale Foundation Board Member Moon Young Lee said, "This is a milestone for both the Everscale and Venom networks. The technological capabilities of Everscale are immense but they have been underappreciated by a wider audience. Now, Everscale will be able to operate as an experimental network where updates and complex technical solutions can be introduced before they are brought to Venom. This investment will allow Everscale to gain the recognition that it deserves."

 

Designed as a network of blockchains, Venom has no limit to the number of other auxiliary networks at the Layer 2 level and no limit to the economy type or operation at the Layer 2. This particular architecture means that mass adoption is now achievable on the Venom blockchain.

About Everscale

Powered by an infinite sharding mechanism, the Everscale network adapts to any workload it is tasked with, without the size of the load affecting transaction times or processing fees. This makes it the ideal blockchain for hosting high-scale web3 and other load-intensive projects. Over the past two years, Everscale has emerged as one of the leading blockchains in Asia, with a thriving community and robust ecosystem of DeFi platforms.

 

More About the Everscale network:

Website | Twitter | Whitepaper | Github | Telegram Ann | Telegram | Discord

About Iceberg Capital

ICEBERG Capital Limited is regulated by FSRA as a Prudential Category 3C investment manager based in ADGM. ICEBERG capital is a fast-growing alternative asset management company that provides diversified investment management platforms that includes direct and private equity, venture capital, technology, and virtual assets. ICEBERG capital also offers traditional asset management services such as investment portfolios as well as specialized platforms for securities, and blockchain technology.

 

For media inquiries, please contact: Abdullah Al Weshah, abdullah@icebergcapital.ae

For more information about Iceberg Capital, visit: Website | LinkedIn

About Venom Foundation

Venom is the world’s first regulated blockchain. The decentralized network operates under the jurisdiction of the ADGM, with a license to issue utility tokens. The ADGM is an oasis for investors and financial services firms, positioning Venom as the world’s first compliant blockchain, affording authorities and enterprises the freedom to build, innovate, and scale.

A portfolio of in-house dApps and protocols has been developed on the Venom blockchain by various companies. It now harbors the potential to become a bridge for the adoption of CBDCs in the Middle East, North Africa, and worldwide.

 

For media inquiries, please contact: Adam Newton, pr@venom.ventures  

For more information about Venom Ventures, visit: Website  |  Twitter

For more information about Venom Foundation, visit: Website  |  Twitter

– END –



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1547947  31-Jan-2023 

fncls.ssp?fn=show_t_gif&application_id=1547947&application_name=news&site_id=symex

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière